发明名称 An oral controlled drug delivery system in the form of a multiparticulate or monolithic system that is buoyant in gastric fluid
摘要 Described is a gastro-retentive oral drug delivery system structurally comprised of a highly porous matrix comprising a drug, gas generating components, sugar, release controlling agents and, optionally, spheronising agents. The pharmaceutical composition, either in the form of pellets (multiparticulate or single unit dosage form), beads, granules or capsules, is retained in the stomach while selectively delivering the drug at the gastric levels and upper parts of small intestine over an extended period of time.
申请公布号 NZ516959(A) 申请公布日期 2003.10.31
申请号 NZ20000516959 申请日期 2000.08.01
申请人 RANBAXY LABORATORIES LIMITED 发明人 TALWAR, NARESH;TOBYN, MICHAEL J;STANIFORTH, JOHN N
分类号 A61K9/00;A61K9/16;A61K9/20;A61K9/30;A61K9/46;A61K9/48;A61K47/02;A61K47/04;A61K47/12;A61K47/18;A61K47/20;A61K47/26;A61K47/30;A61K47/32;A61K47/36;A61K47/38;A61K47/42;A61K47/44;A61K47/46;(IPC1-7):A61K9/46 主分类号 A61K9/00
代理机构 代理人
主权项
地址